Descriptions of her medical experiences differ in the dates, diagnoses, and procedures they mention. This variation does not necessarily mean that the accounts are invented, but it does mean that readers should be cautious about treating them as precise medical history. The caution cuts in both directions. It would be wrong to dismiss the reports entirely, because they are widespread and persistent, and because they may rest on information shared by family members or staff that was never published in a form historians can check. It would be equally wrong to treat them as established fact, because they cannot be verified and because they conflict with one another. The middle position — that she is reported to have had breast cancer and later ovarian cancer, that she is reported to have been treated in the United States, and that the details are uncertain — is less satisfying than a definite story, but it is the only position the evidence supports. Readers who want certainty about her medical history will not find it in the public record, and health writers who offer it are offering something they do not have.
What can be said confidently is that her exceptionally long life has encouraged generations of readers to think about health, aging, and the choices that may support well-being. That encouragement is real, and it is valuable, provided it is channelled toward choices that are supported by evidence rather than toward imitation of a single person's unverified habits. If her story prompts a reader to eat more vegetables, to walk daily, to stop smoking, to attend screening appointments, or to take sleep seriously, then the story has done good work, even if the causal link between her habits and her lifespan can never be proved. The risk is when the story prompts a reader to delay proven treatment in favour of a food or a traditional remedy, or to believe that a particular diet makes cancer impossible. That risk is not hypothetical: cancer charities and oncologists regularly encounter patients who have been misled by survivor stories into believing that diet alone can control a tumour. The rest of this chapter therefore sets out what modern medicine actually knows about breast and ovarian cancer, so that the reported diagnoses can be understood in their proper context, without exaggeration and without fear.
It is also essential to avoid interpreting her survival as proof that a particular food, traditional practice, or daily routine can prevent or cure cancer. Such conclusions would require evidence far stronger than anecdotal accounts. The standard of evidence in medicine is deliberately demanding, and for good reason. To say that a food prevents cancer, researchers need large, long-term studies in which people who eat more of that food develop cancer less often than similar people who eat less of it, after accounting for other differences such as smoking, weight, exercise, and family history; and ideally, they need randomised trials or a consistent pattern across many independent studies. To say that a practice cures cancer, they need trials in which patients receiving that practice do better than patients receiving standard care or a placebo. No single person's story, however striking, can meet that standard, because a single person has no comparison group. She may have eaten celery every day and survived cancer, but without knowing what would have happened if she had not eaten celery, the celery cannot be credited. That is not scepticism for its own sake. It is the logic that protects patients from false hope and from treatments that do not work.
Cancer is not a single disease. Different cancers vary greatly in their causes, biological behavior, response to treatment, and prognosis. A treatment that helps one person may not help another, and a lifestyle that supports general health cannot be assumed to control a specific cancer. There are more than two hundred types of cancer, and even within a single type — breast cancer, for example — there are subtypes that behave very differently, respond to different drugs, and carry very different prognoses. Breast cancer alone includes hormone-sensitive tumours that grow slowly and respond to hormone therapy, HER2-positive tumours that respond to targeted antibodies, and triple-negative tumours that are harder to treat and more likely to recur. Ovarian cancer, likewise, includes several subtypes, and it is often diagnosed late because its early symptoms are vague, which is one reason its overall survival is lower than that of breast cancer. A story that says simply "she had cancer and survived" therefore conceals almost everything a doctor would need to know to understand the outcome. It is like saying "she had an infection and recovered" without saying whether it was a cold or meningitis.
Even people diagnosed with the same type of cancer may experience very different disease courses depending on the stage at diagnosis, the characteristics of the tumor, their overall health, and their access to treatment. Stage — how large the tumour is, whether it has spread to lymph nodes, and whether it has spread to distant organs — is the single most important predictor of outcome for most cancers, and it is precisely the information that is missing from the popular accounts of Soong Mei-ling. A small, localised breast cancer found early and removed surgically can have a five-year survival above ninety percent, according to the American Cancer Society and the National Cancer Institute, while a cancer that has already spread widely at diagnosis has a far lower survival, whatever the patient eats or does afterwards. Access to treatment matters just as much: a patient treated promptly at a leading American hospital, with surgery, radiotherapy, and the best available drugs, has a different outlook from a patient with the same disease but no access to care. Soong Mei-ling, as the wife of a head of government and later as a wealthy resident of New York, had access to medical care of a standard that most people in China in the mid-twentieth century could not have imagined. That access is part of the story, and any account of her survival that omits it is incomplete.
Breast cancer, the first of the two reported diagnoses, is the most common cancer in women worldwide, with about 2.3 million new cases each year according to the World Health Organization, and it is also one of the most treatable when found early. Its risk rises with age, with family history, with certain inherited gene changes such as BRCA1 and BRCA2, with reproductive history, with alcohol use, with excess weight after the menopause, and with physical inactivity. Its treatment has been transformed over the past fifty years: from radical surgery alone to a combination of breast-conserving surgery, radiotherapy, hormone therapy, chemotherapy, and targeted drugs, chosen according to the tumour's biology. Survival has improved steadily in high-income countries, and the American Cancer Society reports that the overall five-year survival for breast cancer in the United States is now around ninety percent, and above ninety-nine percent when the cancer is localised. Those figures are averages across millions of women, and they make an important point: long-term survival after breast cancer, while always a cause for gratitude, is not in itself extraordinary. Millions of women live for decades after a breast cancer diagnosis. If Soong Mei-ling was one of them, her survival is consistent with what modern oncology expects for an early-stage, well-treated case, and it does not require a special dietary explanation.
Ovarian cancer, the second reported diagnosis, is a different and more difficult disease. It is less common than breast cancer — about 324,000 new cases a year worldwide, according to the World Health Organization — but it is more often fatal, because it is usually found after it has spread within the abdomen. Its symptoms in the early stages, such as bloating, pelvic discomfort, and changes in appetite, are easy to mistake for minor digestive problems, and there is no reliable screening test for women at average risk, which is why major guidelines do not recommend routine ovarian screening. Treatment typically involves surgery to remove as much of the tumour as possible, followed by chemotherapy, and in recent years targeted drugs such as PARP inhibitors have improved outcomes for some women, particularly those with BRCA gene changes. Even so, the overall five-year survival remains around fifty percent in high-income countries, and long-term survival after ovarian cancer is less common than after breast cancer. If the reports of a later ovarian cancer are accurate, her survival for many years afterwards would be more unusual, and more suggestive of either a very early-stage tumour, a slow-growing subtype, or an exceptionally good response to treatment. But again, without the stage and the pathology, that suggestion cannot be turned into a conclusion, and it certainly cannot be turned into a claim about diet.
The responsible way to read the cancer story, then, is as a prompt rather than as proof. It prompts questions that medicine can answer in general terms: how are breast and ovarian cancers found, how are they treated, what improves the odds, and what should a reader do if they are worried about their own risk? The answers to those questions are clear, and they are worth stating plainly. Women should know the normal look and feel of their breasts and report changes promptly; mammography screening, as recommended by national guidelines, finds cancers earlier, when treatment works best; a family history of breast or ovarian cancer, especially at a young age or in several relatives, should be discussed with a doctor, who may suggest genetic counselling; and symptoms that persist — a lump, nipple change, persistent bloating, pelvic pain, or unexplained weight loss — should be checked without delay. None of those steps depends on Soong Mei-ling's story, and none of them is a substitute for medical care. But her story, read carefully, can lead a reader toward them, and that is its most useful function.
Chapter 3: Why One Person Lives to 105 — Genetics, Luck, Care, and Circumstance